Pfizer Inc (NYSE:PFE) has a beta value of 0.53 and has seen 9.07 million shares traded in the recent trading session. The company, currently valued at $133.21B, closed the recent trade at $23.43 per share which meant it lost -$0.06 on the day or -0.26% during that session. The PFE stock price is -34.61% off its 52-week high price of $31.54 and 10.71% above the 52-week low of $20.92. If we look at the company’s 10-day average daily trading volume, we find that it stood at 39.89 million shares traded. The 3-month trading volume is 53.81 million shares.
The consensus among analysts is that Pfizer Inc (PFE) is Buy stock at the moment, with a recommendation rating of 2.38. 1 analysts rate the stock as a Sell, while 1 rate it as Overweight. 7 out of 16 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Pfizer Inc (NYSE:PFE) trade information
Over the past 30 days, the shares of Pfizer Inc (NYSE:PFE) have changed -2.09%. Short interest in the company has seen 107.38 million shares shorted with days to cover at 2.14.
Wall Street analysts have a consensus price target for the stock at $28, which means that the shares’ value could jump 16.32% from the levels at last check today.. The projected low price target is $24.0 while the price target rests at a high of $32.0. In that case, then, we find that the latest price level in today’s session is -36.58% off the targeted high while a plunge would see the stock gain -2.43% from the levels at last check today..
Pfizer Inc (PFE) estimates and forecasts
The company’s shares have lost -9.08% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -13.25% over the past 5 years. Earnings growth for 2025 is a modest -3.50% while over the next 5 years, the company’s earnings are expected to decrease by -0.27%.
PFE Dividends
Pfizer Inc is expected to release its next earnings report on 2025-Apr-28 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.70 at a share yield of 7.26%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 4.54%.
Pfizer Inc (NYSE:PFE)’s Major holders
Insiders own 0.06% of the company shares, while shares held by institutions stand at 67.57% with a share float percentage of 67.61%. Investors are also buoyed by the number of investors in a company, with Pfizer Inc having a total of 3690.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 511.4 million shares worth more than $14.31 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.0258% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 424.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.87 billion and represent 7.4899% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.15% shares in the company for having 179.04 shares of worth $4.2 billion while later fund manager owns 157.46 shares of worth $3.69 billion as of Mar 31, 2025 , which makes it owner of about 2.77% of company’s outstanding stock.
